Transcriptome and molecular endocrinology aspects of epicardial adipose tissue in cardiovascular diseases: A systematic review and meta-analysis of observational studies

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Maghbooli, Zhila ^a   Hossein Nezhad, Arash ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; C REACTIVE PROTEIN; INTERLEUKIN 6; PROTEIN P53; TRANSCRIPTOME; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; AGING; APOPTOSIS; ARTERIAL PRESSURE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; EPICARDIAL ADIPOSE TISSUE; EPICARDIUM; GENE EXPRESSION; HUMAN; NONHUMAN; OBSERVATIONAL STUDY; PROTEIN PROTEIN INTERACTION; QUALITY CONTROL; REVIEW; SUBCUTANEOUS FAT; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; META ANALYSIS; METABOLISM; PERICARDIUM; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADIPOSE TISSUE; BIOMARKERS; CARDIOVASCULAR DISEASES; HUMANS; INTERLEUKIN-6; OBSERVATIONAL STUDIES AS TOPIC; PERICARDIUM; PREVALENCE; RISK FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84948397884     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/926567     Document Type: Review

References (90)

1. M. G. Farb and N. Gokce, "Visceral adiposopathy: a vascular perspective," Hormone Molecular Biology and Clinical Investigation, vol. 21, pp. 125-136, 2015.
2. S. Lemieux, A. Bédard, M.-É. Piché, S. J. Weisnagel, L. Corneau, and J. Bergeron, "Visceral adipose tissue accumulation and cardiovascular disease risk profle in postmenopausal women with impaired glucose tolerance or type 2 diabetes," Clinical Endocrinology, vol. 74, no. 3, pp. 340-345, 2011.
3. M. Murri, M. Insenser, M. R. Bernal-Lopez, P. Perez-Martinez, H. F. Escobar-Morreale, and F. J. Tinahones, "Proteomic analysis of visceral adipose tissue in pre-obese patients with type 2 diabetes," Molecular and Cellular Endocrinology, vol. 376, no. 1-2, pp. 99-106, 2013.
4. K. Osawa, T. Miyoshi, Y. Koyama et al., "Diferential association of visceral adipose tissue with coronary plaque characteristics in patients with and without diabetes mellitus," Cardiovascular Diabetology, vol. 13, no. 1, article 61, 2014.
5. J. D. Smith, A.-L. Borel, J.-A. Nazare et al., "Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE me IAA study," Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 5, pp. 1517-1525, 2012.
6. J. M. McGavock, R. G. Victor, R. H. Unger, and L. S. Szczepa-niak, "Adiposity of the heart, revisited," Annals of Internal Medicine, vol. 144, no. 7, pp. 517-524, 2006.
7. B. Gaborit, I. Abdesselam, and A. Dutour, "Epicardial fat: more than just an epi phenomenon?" Hormone and Metabolic Research, vol. 45, no. 13, pp. 991-1001, 2013.
8. G. Iacobellis, D. Corradi, and A. M. Sharma, "Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart," Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 10, pp. 536-543, 2005.
9. T. Mazurek, L. Zhang, A. Zalewski et al., "Human epicardial adipose tissue is a source of infammatory mediators," Circulation, vol. 108, no. 20, pp. 2460-2466, 2003.
10. G. Iacobellis and F. Leonetti, "Epicardial adipose tissue and insulin resistance in obese subjects," Te Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 11, pp. 6300-6302, 2005.
11. S. W. Rabkin, "Te relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis," Metabolic Syndrome and Related Disorders, vol. 12, no. 1, pp. 31-42, 2014.
12. G. Iacobellis and A. M. Sharma, "Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome," Current Pharmaceutical Design, vol. 13, no. 21, pp. 2180-2184, 2007.
13. Y. Benjamini, D. Drai, G. Elmer, N. Kafaf, and I. Golani, "Controlling the false discovery rate in behavior genetics research," Behavioural Brain Research, vol. 125, no. 1-2, pp. 279-284, 2001.
14. A. Reiner, D. Yekutieli, and Y. Benjamini, "Identifying difer-entially expressed genes using false discovery rate controlling procedures," Bioinformatics, vol. 19, no. 3, pp. 368-375, 2003.
15. D. W. Huang, B. T. Sherman, and R. A. Lempicki, "Systematic and integrative analysis of large gene lists using DAVID bioin-formatics resources," Nature Protocols, vol. 4, no. 1, pp. 44-57, 2009.
16. A. Franceschini, D. Szklarczyk, S. Frankild et al., "STRING v9.1: protein-protein interaction networks, with increased coverage and integration," Nucleic Acids Research, vol. 41, no. 1, pp. D808-D815, 2013.
17. R. M. Agra, E. Teijeira-Ferńandez, D. Pascual-Figal et al., "Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients," European Journal of Clinical Investigation, vol. 44, no. 1, pp. 29-37, 2014.
18. F. Atalar, B. Vural, C. Cifci et al., "11beta-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease," Genetics and Molecular Research, vol. 11, no. 3, pp. 3122-3132, 2012.
19. A. R. Baker, A. L. Harte, N. Howell et al., "Epicardial adipose tissue as a source of nuclear factor-κB and c-Jun N-terminal kinase mediated infammation in patients with coronary artery disease," Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 1, pp. 261-267, 2009.
20. A. R. Baker, N. F. D. Silva, D. W. Quinn et al., "Human epicardial adipose tissue expresses a pathogenic profle of adipocytokines in patients with cardiovascular disease," Cardiovascular Dia-betology, vol. 5, article 1, 2006.
21. C. Bambace, A. Sepe, E. Zoico et al., "Infammatory profle in subcutaneous and epicardial adipose tissue in men with and without diabetes," Heart and Vessels, vol. 29, no. 1, pp. 42-48, 2014.
22. C. Bambace, M. Telesca, E. Zoico et al., "Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men," Cardiovascular Pathology, vol. 20, no. 5, pp. e153-e156, 2011.
23. G. Cappellano, F. Uberti, P. P. Caimmi et al., "Diferent expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease," Canadian Journal of Cardiology, vol. 29, no. 4, pp. 499-509, 2013.
24. R. B. Castro, C. A. Longui, C. D. Faria et al., "Tissue-specifc adaptive levels of glucocorticoid receptor alpha mRNA and their relationship with insulin resistance," Genetics and Molecular Research, vol. 11, no. 4, pp. 3975-3987, 2012.
25. E. Dozio, G. Dogliotti, A. E. Malavazos et al., "IL-18 level in patients undergoing coronary artery bypass grafing surgery or valve replacement: which link with epicardial fat depot?" International Journal of Immunopathology and Pharmacology, vol. 25, no. 4, pp. 1011-1020, 2012.
26. E. Dozio, A. E. Malavazos, E. Vianello et al., "Interleukin-15 and soluble interleukin-15 receptor α in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution," PLoS ONE, vol. 9, no. 3, Article ID e90960, 2014.
27. A. Dutour, V. Achard, H. Sell et al., "Secretory type II phospho-lipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease," Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 2, pp. 963-967, 2010.
28. S. Eiras, E. Teijeira-Fernández, A. Salgado-Somoza et al., "Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression," Cytokine, vol. 51, no. 2, pp. 207-212, 2010.
29. S. Eiras, E. Teijeira-Ferńandez, L. G. Shamagian, A. L. Fernandez, A. Vazquez-Boquete, and J. R. Gonzalez-Juanatey, "Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue," Cytokine, vol. 43, no. 2, pp. 174-180, 2008.
30. J. N. Fain, H. S. Sacks, B. Buehrer et al., "Identifcation of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots," International Journal of Obesity, vol. 32, no. 5, pp. 810-815, 2008.
31. R. Fandiño-Vaquero, A. Fernández-Trasancos, E. Álvarez et al., "Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or infammation in coronary artery disease," Journal of Membrane Science, vol. 467, pp. 281-288, 2014.
32. X. Gao, S. Mi, F. Zhang et al., "Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis," Cardiovascular Diabetology, vol. 10, article 87, 2011.
33. S. Gormez, A. Demirkan, F. Atalar et al., "Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease," Internal Medicine, vol. 50, no. 8, pp. 805-810, 2011.
34. G. Iacobellis, C. R. Di Gioia, M. Di Vito et al., "Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease," Hormone and Metabolic Research, vol. 41, no. 12, pp. 855-860, 2009.
35. M. J. Iglesias, S. Eiras, R. Piñeiro et al., "Gender diferences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery," Revista Espanola de Cardiologia, vol. 59, no. 12, pp. 1252-1260, 2006.
36. I. Jafer, M. Riederer, P. Shah et al., "Expression of fat mobilizing genes in human epicardial adipose tissue," Atherosclerosis, vol. 220, no. 1, pp. 122-127, 2012.
37. S. Langheim, L. Dreas, L. Veschini et al., "Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome," Te American Journal of Physiology\-Heart and Circulatory Physiology, vol. 298, no. 3, pp. H746-H753, 2010.
38. R. M. Agra, E. Teijeira-Fernández, D. Pascual-Figal et al., "Diferential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat," Life Sciences, vol. 100, no. 2, pp. 147-151, 2014.
39. L. Nasarre, O. Juan-Babot, P. Gastelurrutia et al., "Low density lipoprotein receptor-related protein 1 is upregulated in epicar-dial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels," Acta Diabetologica, vol. 51, no. 1, pp. 23-30, 2014.
40. B. K. Rodiño-Janeiro, A. Salgado-Somoza, E. Teijeira-Fernández, J. R. González-Juanatey, E. Álvarez, and S. Eiras, "Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease," European Journal of Endocrinology, vol. 164, no. 4, pp. 529-537, 2011.
41. H. S. Sacks, J. N. Fain, P. Cheema et al., "Depot-Specifc overexpression of proinfammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis," Metabolic Syndrome and Related Disorders, vol. 9, no. 6, pp. 433-439, 2011.
42. H. S. Sacks, J. N. Fain, P. Cheema et al., "Infammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone," Diabetes Care, vol. 34, no. 3, pp. 730-733, 2011.
43. H. S. Sacks, J. N. Fain, B. Holman et al., "Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat," Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3611-3615, 2009.
44. A. Salgado-Somoza, E. Teijeira-Fernández, Á . L. Fernández, J. R. González-Juanatey, and S. Eiras, "Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease," Atherosclerosis, vol. 224, no. 2, pp. 492-499, 2012.
45. A. Salgado-Somoza, E. Teijeira-Fernández, Á. Luis Fernandez, J. Ramon Gonzalez-Juanatey, and S. Eiras, "Proteomic analysis of epicardial and subcutaneous adipose tissue reveals diferences in proteins involved in oxidative stress," The American Journal of Physiology\-Heart and Circulatory Physiology, vol. 299, no. 1, pp. H202-H209, 2010.
46. A. Salgado-Somoza, E. Teijeira-Fernández, J. Rubio, E. Couso, J. R. González-Juanatey, and S. Eiras, "Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epi-cardial and subcutaneous adipose tissue," Clinical Endocrinology, vol. 76, no. 1, pp. 51-58, 2012.
47. I. Shibasaki, T. Nishikimi, Y. Mochizuki et al., "Greater expression of infammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease," Regulatory Peptides, vol. 165, no. 2-3, pp. 210-217, 2010.
48. M. Shimabukuro, Y. Hirata, M. Tabata et al., "Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis," Arteriosclerosis, Trombosis, and Vascular Biology, vol. 33, no. 5, pp. 1077-1084, 2013.
49. A. Silaghi, V. Achard, O. Paulmyer-Lacroix et al., "Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status," American Journal of Physiology\-Endocrinology and Metabolism, vol. 293, no. 5, pp. E1443-E1450, 2007.
50. A. Silaghi, H. Silaghi, T. Scridon, R. Pais, and V. Achard, "Gluco-corticoid receptors in human epicardial adipose tissue: role of coronary status," Journal of Endocrinological Investigation, vol. 35, no. 7, pp. 649-654, 2012.
51. E. Teijeira-Fernandez, S. Eiras, L. G. Shamagian, A. S. Somoza, C. Delgado, and J. R. Gonzalez-Juanatey, "Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome," Cytokine, vol. 54, no. 2, pp. 185-190, 2011.
52. E. Teijeira-Fernandez, S. Eiras, L. Grigorian-Shamagian, A. Fernandez, B. Adrio, and J. R. Gonzalez-Juanatey, "Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension," Journal of Human Hypertension, vol. 22, no. 12, pp. 856-863, 2008.
53. E. Teijeira-Fernandez, S. Eiras, L. Grigorian-Shamagian, A. Salgado-Somoza, J. M. Martinez-Comendador, and J. R. Gonzalez-Juanatey, "Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels," International Journal of Obesity, vol. 34, no. 7, pp. 1200-1208, 2010.
54. E. Teijeira-Fernandez, S. Eiras, A. Salgado Somoza, and J. R. Gonzalez-Juanatey, "Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study," Cytokine, vol. 60, no. 3, pp. 674-680, 2012.
55. B. Vural, F. Atalar, C. Cifci et al., "Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome," Cardiovascular Pathology, vol. 17, no. 6, pp. 392-398, 2008.
56. Y. Zhou, Y. Wei, L. Wang et al., "Decreased adiponectin and increased infammation expression in epicardial adipose tissue in coronary artery disease," Cardiovascular Diabetology, vol. 10, article 2, 2011.
57. E. Dozio, S. Briganti, E. Vianello et al., "Epicardial adipose tissue infammation is related to vitamin D defciency in patients afected by coronary artery disease," Nutrition, Metabolism and Cardiovascular Diseases, vol. 25, no. 3, pp. 267-273, 2015.
58. H. Imoto-Tsubakimoto, T. Takahashi, T. Ueyama et al., "Ser-glycin is a novel adipocytokine highly expressed in epicardial adipose tissue," Biochemical and Biophysical Research Communications, vol. 432, no. 1, pp. 105-110, 2013.
59. K. Chechi, P.-G. Blanchard, P. Mathieu, Y. Deshaies, and D. Richard, "Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease," International Journal of Cardiology, vol. 167, no. 5, pp. 2264-2270, 2013.
60. M. Vokurka, Z. Lacinova, J. Kremen et al., "Hepcidin expression in adipose tissue increases during cardiac surgery," Physiological Research, vol. 59, no. 3, pp. 393-400, 2010.
61. J. Kremen, M. Dolinkova, J. Krajickova et al., "Increased subcutaneous and epicardial adipose tissue production of proinfammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance," Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4620-4627, 2006.
62. H. S. Sacks, J. N. Fain, S. W. Bahouth et al., "Adult epicardial fat exhibits beige features," Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 9, pp. E1448-E1455, 2013.
63. J. N. Fain, H. S. Sacks, S. W. Bahouth, D. S. Tichansky, A. K. Madan, and P. S. Cheema, "Human epicardial adipokine messenger RNAs: comparisons of their expression in subster-nal, subcutaneous, and omental fat," Metabolism: Clinical and Experimental, vol. 59, no. 9, pp. 1379-1386, 2010.
64. R. Baumann, N. Lee, S. Nicoloro et al., "Human epicardial fat shares molecular and morphologic features of omental fat," Circulation, vol. 128, Article ID A17549, 2013.
65. S. Guauque-Olarte, N. Gaudreault, M.-È. Piche et al., "Te tran-scriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease," PLoS ONE, vol. 6, no. 5, Article ID e19908, 2011.
66. M. Nichols, N. Townsend, P. Scarborough, and M. Rayner, "Cardiovascular disease in Europe 2014: epidemiological update," European Heart Journal, vol. 35, no. 42, pp. 2950-2959, 2014.
67. K. Toczyłowski, M. Gruca, and M. Baranowski, "Epicardial adipose tissue and its role in cardiac physiology and disease," Postepy Higieny i Medycyny Doswiadczalnej, vol. 67, pp. 584-593, 2013.
68. M. Çetin, T. Erdoʇan, S. A. Kocaman et al., "Increased epicardial adipose tissue in patients with isolated coronary artery ectasia," Internal Medicine, vol. 51, no. 8, pp. 833-838, 2012.
69. M. L. McKenney, K. A. Schultz, J. H. Boyd et al., "Epicardial adipose excision slows the progression of porcine coronary atherosclerosis," Journal of Cardiothoracic Surgery, vol. 9, article 2, 2014.
70. P. M. Kang and S. Izumo, "Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases," Trends in Mole cular Medicine, vol. 9, no. 4, pp. 177-182, 2003.
71. 2-induced myocar-dial apoptosis: a missing link between obesity and cardiovascular disease," Journal of Cellular Physiology, vol. 228, no. 3, pp. 495-501, 2013.
72. J. M. Hare, "Oxidative stress and apoptosis in heart failure progression," Circulation Research, vol. 89, no. 3, pp. 198-200, 2001.
73. K.-H. Cheng, C.-S. Chu, K.-T. Lee et al., "Adipocytokines and proinfammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease," International Journal of Obesity, vol. 32, no. 2, pp. 268-274, 2008.
74. H. Noshad, H. Argani, N. Nezami et al., "Arterial atherosclerosis in patients with chronic kidney disease and its relationship with serum and tissue," Iranian Journal of Kidney Diseases, vol. 3, no. 4, pp. 203-209, 2009.
75. A. P. Pilbrow, B. R. Palmer, C. M. Frampton et al., "Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure," Hypertension, vol. 49, no. 2, pp. 322-327, 2007.
76. T. Roubicek, M. Dolinkova, J. Blaha et al., "Increased angiotensinogen production in epicardial adipose tissue during cardiac surgery: possible role in a postoperative insulin resistance," Physiological Research, vol. 57, no. 6, pp. 911-917, 2008.
77. J. Scheller, A. Chalaris, D. Schmidt-Arras, and S. Rose-John, "Te pro-and anti-infammatory properties of the cytokine interleukin-6," Biochimica et Biophysica Acta, vol. 1813, no. 5, pp. 878-888, 2011.
78. T. Hou, B. C. Tieu, S. Ray et al., "Roles of IL-6-gp130 signaling in vascular infammation," Current Cardiology Reviews, vol. 4, no. 3, pp. 179-192, 2008.
79. J. Nair, M. Ghatge, V. V. Kakkar, and J. Shanker, "Network analysis of infammatory genes and their transcriptional regulators in coronary artery disease," PLoS ONE, vol. 9, no. 4, Article ID e94328, 2014.
80. D. Menendez, A. Inga, and M. A. Resnick, "Te expanding universe of p53 targets," Nature Reviews Cancer, vol. 9, no. 10, pp. 724-737, 2009.
81. J. A. Royds and B. Iacopetta, "p53 and disease: when the guardian angel fails," Cell Death & Diferentiation, vol. 13, no. 6, pp. 1017-1026, 2006.
82. K. H. Vousden and D. P. Lane, "p53 in health and disease," Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 275-283, 2007.
83. J. Mercer, M. Mahmoudi, and M. Bennett, "DNA damage, p53, apoptosis and vascular disease," Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 621, no. 1-2, pp. 75-86, 2007.
84. G. L. Semenza, "Mechanisms of disease: oxygen sensing, home-ostasis, and disease," The New England Journal of Medicine, vol. 365, no. 6, pp. 537-547, 2011.
85. Y. Huang, R. P. Hickey, J. L. Yeh et al., "Cardiac myocyte-specifc HIF-1alpha deletion alters vascularization, energy availability, calcium fux, and contractility in the normoxic heart," The FAS E B Journal, vol. 18, no. 10, pp. 1138-1140, 2004.
86. P. Trayhurn, B. Wang, and I. S. Wood, "Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?" British Journal of Nutrition, vol. 100, no. 2, pp. 227-235, 2008.
87. N. Halberg, T. Khan, M. E. Trujillo et al., "Hypoxia-inducible factor 1α induces fbrosis and insulin resistance in white adipose tissue," Molecular and Cellular Biology, vol. 29, no. 16, pp. 4467-4483, 2009.
88. N.-H. Kim and P. M. Kang, "Apoptosis in cardiovascular diseases: mechanism and clinical implications," Korean Circulation Journal, vol. 40, no. 7, pp. 299-305, 2010.
89. C. Gill, R. Mestril, and A. Samali, "Losing heart: the role of apoptosis in heart disease-a novel therapeutic target?" The FASEB Journal, vol. 16, no. 2, pp. 135-146, 2002.
90. M. N. Sack, R. M. Smith, and L. H. Opie, "Tumor necrosis factor in myocardial hypertrophy and ischaemia-an anti-apoptotic perspective," Cardiovascular Research, vol. 45, no. 3, pp. 688-695, 2000.